Skip to content
Open access

Granzyme K associates with inflammatory immune programs and B-cell dysregulation in systemic lupus erythematosus

Nov 2026 · Frontiers in Immunology · 0 citations · 56 references

TL;DR

Findings identify circulating GZMK as an independent correlate of SLE clinical activity and characterize a recurrent GZMK-enriched CD8 + memory/Tem cell program across peripheral blood and affected tissues that is associated with B-cell dysregulation and plasma-cell-related immune abnormalities.

Abstract

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by systemic immune activation and multi-organ inflammation. Granzyme K (GZMK), a serine protease predominantly expressed by CD8 + T cells and natural killer cells, has emerging non-cytotoxic inflammatory functions, but its relevance to SLE remains incompletely defined. In this study, we conducted investigations using plasma and tissue analyses, single-cell RNA sequencing, proteomics, multiplex immunofluorescence, an animal model, and primary human B cell experiments. Plasma GZMK was increased in patients with SLE and was associated with clinical disease activity. Integrated multi-tissue single cell analysis identified preferential GZMK enrichment in CD8 + effector memory T (Tem) cells and a higher relative abundance of this compartment in SLE, while proteomic profiling and multiplex immunofluorescence provided protein and tissue level evidence for a GZMK-enriched CD8 + memory T cell population. Cell–cell communication analysis suggested enhanced predicted communication between Tem and B lineage cells, and circulating GZMK was further associated with a plasma cell-like population. In two murine models, PPACK, which can inhibit GZMK catalytic activity but is not GZMK selective, attenuated lupus associated inflammatory phenotypes and partially normalized altered splenic B cell composition. In vitro experiments showed that active recombinant GZMK augmented plasma-cell-associated phenotypic and transcriptional responses under B cell expansion conditions. Collectively, these findings identify circulating GZMK as an independent correlate of SLE clinical activity and characterize a recurrent GZMK-enriched CD8 + memory/Tem cell program across peripheral blood and affected tissues that is associated with B-cell dysregulation and plasma-cell-related immune abnormalities.

Read PDF

Similar papers

Review Oct 2026

T-cell dysregulation in systemic lupus erythematosus: a four-layered model from extracellular cues to epigenetic remodeling and therapeutic opportunities.

The spectrum of T-cell abnormalities in SLE is synthesized and it is proposed that these phenotypes arise from four interacting layers of dysregulation: extracellular cues including cytokine and non-cytokine mediators and altered antigen presentation, T-cell receptor (TCR) and co-stimulatory signaling, immunometabolic...

Xiao-Yi Zheng, Hong-Rui Liu, Yong-Kang Chen et al. · 0 citations
Open access Oct 2026

B Cell Interferon-Induced Transmembrane Protein 2: A Candidate Biomarker Associated with Disease Activity in Systemic Lupus Erythematosus

B cell IFITM2 expression is closely associated with disease activity in SLE and may serve as a potential biomarker to improve the discriminatory performance of anti-dsDNA testing, suggesting that combined assessment of IFITM2 and UTP may help reflect renal status in patients with SLE.

Bin Wen, Xiao-Cui Wang, Xue-Mei Duan et al. · 0 citations
Open access Nov 2026

Differentiation and Pathological Significance of Tissue-Resident Memory-Like CD8+ T Cells in Systemic Lupus Erythematosus.

OBJECTIVE Tissue-resident memory T (TRM) cells have been implicated in organ-specific immune pathology; however, the pathological relevance of TRM-like CD8+ T cells in systemic lupus erythematosus (SLE) remains unclear. We investigated their differentiation mechanisms and pathological significance in SLE, including ass...

Yuya Fujita, Kaoru Yamagata, S. Kubo et al. · 0 citations
Review Open access Oct 2026

Therapeutic Strategies Targeting Immune Dysregulation in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease driven by loss of immune tolerance, dysregulated nucleic acid sensing and cytokine signaling, abnormal B- and T-cell activation, persistent autoantibody production, and impaired clearance of immune cells and debris. These interconnected abnormalit...

Yu-Rin Kim, E. Yeo, I. Kang · 0 citations
Open access Nov 2026

T/NK-cell remodeling and IFN-responsive myeloid activation delineate immunometabolic risk profiles in chronic active Epstein-Barr virus disease

Chronic active Epstein-Barr virus disease (CAEBV) is a rare EBV-associated T/NK-cell lymphoproliferative disorder characterized by persistent viral infection, systemic inflammation, and highly variable clinical courses. Patients may develop HLH-like hyperinflammation, severe organ involvement, lymphoma transformati...

Yue Cao, Zhe Zhou, Sheng-Lei Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.